Orgenesis Inc. Dividends Paid (Total)

Dividends Paid (Total) of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Dividends Paid (Total) growth rates and interactive chart.


Highlights and Quick Summary

  • Dividends Paid (Total) for the quarter ending March 30, 2017 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Dividends Paid (Total) decreased by NaN%
  • Annual Dividends Paid (Total) for 2012 was $0
  • Twelve month Dividends Paid (Total) ending March 30, 2017 was $0 (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Dividends Paid (Total) decreased by NaN% year-over-year
Trailing Dividends Paid (Total) for the last four month:
30 Mar '17 30 Dec '16 29 Sep '16 29 Jun '16
$0 $0 $0 $0
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Dividends Paid (Total) of Orgenesis Inc.

Most recent Dividends Paid (Total)of ORGS including historical data for past 10 years.

Interactive Chart of Dividends Paid (Total) of Orgenesis Inc.

Orgenesis Inc. Dividends Paid (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2017 $0.0
2016 $0.0 $0.0 $0.0
2015 $0.0
2014 $0.0
2013 $0.0
2012 $0.0 $0.0

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.